Skip to content

Clinical trials

Phase 2 Blood Coagulation Disorders trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Blood Coagulation Disorders Phase: Phase 2 Clear all

6 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20061
20101
20141
20151
20211

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed3
Terminated2
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Instituto Bioclon S.A. de C.V.1
Peking University People's Hospital1
Pfizer1
Royal Brompton & Harefield NHS Foundation Trust1
Sierra Oncology LLC - a GSK company1
University of Sao Paulo1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Blood Coagulation Disorders6
Blood Platelet Disorders2
Bone Marrow Diseases1
Hematologic Diseases1
Hemophilia B1
Hemorrhage1
Hemorrhagic Disorders1
Myeloproliferative Disorders1
Polycythemia1
Polycythemia Vera1

Trials

Showing 1 to 6 of 6. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.